Malaysia
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 23.39 M
|
Dec. 31, 2023 | USD 0.28 | -0.31% |
|
Malaysia |
|
2 |
USD -5.26 M
|
Dec. 31, 2023 | USD 0.84 | 0.77% |
|
Malaysia |
|
3 |
USD -73.42 M
|
Dec. 31, 2023 | USD 0.54 | -0.31% |
|
Malaysia |
|
4 |
USD -614.16 M
|
Dec. 31, 2023 | USD 1.63 | -0.31% |
|
Malaysia |
The Healthcare company in Malaysia with the highest Net Cash Used Provided By Financing Activities is Duopharma Biotech Berhad (Kuala Lumpur Stock Exchange: 7148.KL) at USD 23.39 M.
The Healthcare company in Malaysia with the lowest Net Cash Used Provided By Financing Activities is IHH Healthcare Berhad (Kuala Lumpur Stock Exchange: 5225.KL) at USD -614.16 M.
The top 10 Healthcare companies in Malaysia by Net Cash Used Provided By Financing Activities are Duopharma Biotech Berhad, Pentamaster Corporation Berhad, KPJ Healthcare Berhad and IHH Healthcare Berhad.
The bottom 10 Healthcare companies in Malaysia by Net Cash Used Provided By Financing Activities are IHH Healthcare Berhad, KPJ Healthcare Berhad, Pentamaster Corporation Berhad and Duopharma Biotech Berhad.